Most hypertensive crises represent failure of medical management and are preventable by appropriate early identification and therapy. Controlled therapeutic trials in patients with severe hypertension have clearly demonstrated that control of blood pressure can prevent accelerated hypertension and aortic dissection. The number of other complications such as congestive heart failure, progressive azotemia, stroke, and hypertensive neuroretinopathy is also considerably reduced by aggressive antihypertensive therapy.
Although hypertensive emergencies are not common, they still represent a major management problem for emergency room and primary care physicians. Severe and sudden elevation in blood pressure, regardless of cause, is a direct threat to life. In such situations, rapid reduction of blood pressure by parenteral administration of antihypertensive drugs is urgently indicated if the integrity of the cardiovascular system is to be maintained. Prompt reduction of blood pressure will reduce both the morbidity and mortality from hypertensive crises. 
Hypertensive crises

Further diagnostic studies
Additional studies are undertaken only after blood pressure has been controlled or reduced to a level determined to represent adequate control for the individual patient. Treatment should be delayed for only a brief history and physical evaluation aimed at excluding a catecholamine-related form of hypertension and assessing the cerebrovascular, coronary vascular, and cardiovascular status of the patient. These few studies will enable the physician to assess the target organ status of the patient before instituting therapy with parenteral antihypertensive agents.
Method of administration of antihypertensive drugs
In the management of hypertensive emergencies, blood pressure must be reduced without delay and hypotensive agents should, therefore, be administered parenterally. The simplest method is to inject intramuscularly the chosen agent (reserpine, hydralazine) in adequate doses as often as necessary to keep the blood pressure within the desired range. When blood pressure must be reduced more promptly, intravenous injections may be given and repeated intermittently by slowly injecting the drug (hydralazine, pentolinium) directly from a syringe at intervals, or by bolus injection of an agent such as diazoxide; or a continuous infusion (sodium nitroprusside, trimethaphan) may be administered under constant supervision.
Drugs available for treatment of hypertensive emergencies (Tables 1 and 2)
To combat hypertensive crises, the drugs available for parenteral administration can be classified according to their mechanisms of action into those that directly dilate the resistance vessels and, therefore, reduce peripheral resistance and those that act to interfere with sympathetic innervation of the cardiovascular system.
Direct vasodilators
Diazoxide
Our experience has demonstrated that in approximately 85% of administered doses, diazoxide is effective when given rapidly by intravenous push (15 to 20 seconds) from a syringe without diluting the commercial preparation. The usual bolus dose is 300 mg (5 mg/ kg of body weight).
In patients with recognized or suspected cerebrovascular or coronary vascular insufficiency, an intermittent pulse administration may be preferred. Fifty to 100 mg of diazoxide is injected rapidly at 5-to 15-minute intervals, thus allowing a more gradual reduction in blood pressure in contrast to the precipitous reduction which occurs following an effective 300-mg bolus. this is an advantage in acute heart failure 5. Does not cause sedation or somnolence
Disadvantages
The rapidity of onset and evanescent effect necessitate constant observation by trained personnel in an intensive care setting if wide fluctuations in blood pressure are to be avoided
Sympathetic inhibitors
Reserpine
This agent is not used as frequently as it was before the advent of diazoxide and sodium nitroprusside.
fore, larger doses are required for bedfast patients 3. Repeated administration leads to parasympatholytic side effects (i.e., urinary retention, paralytic ileus)
Methyldopate ester
Methyldopa is less effective than reserpine but has the same disadvantages and must be given intravenously.
